Andrew G Long
CIK 1714880 · EVP, CEO P&HS · last filed 2025-11-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
31
Lifetime Open-Market Net
-$944.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACCENDRA HEALTH INC/VA/ (OMI) Delisted | EVP, CEO P&HS | 448,425 | $2.80 | $1.26M | -$944.6K | 25 | 2025-11-20 |
| Insys Therapeutics, Inc. (INSY) Delisted | Chief Executive Officer | 62,075 | — | — | $0 | 6 | 2019-06-05 |
Recent Filings · Page 3 of 4
31 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-05-13 | ACCENDRA HEALTH INC/VA/ (OMI) Delisted | Tax (F) | −4,941 | -$165.1K | EDGAR |
| 2021-03-03 | ACCENDRA HEALTH INC/VA/ (OMI) Delisted | Grant (A) | +27,827 | $0 | EDGAR |
| 2020-11-12 | ACCENDRA HEALTH INC/VA/ (OMI) Delisted | Tax (F) | −5,118 | -$113.5K | EDGAR |
| 2020-05-13 | ACCENDRA HEALTH INC/VA/ (OMI) Delisted | Grant (A) | +48,276 | $0 | EDGAR |
| 2019-11-12 | ACCENDRA HEALTH INC/VA/ (OMI) Delisted | Grant (A) | +50,000 | $0 | EDGAR |
| 2019-06-05 | Insys Therapeutics, Inc. (INSY) Delisted | Grant (A) | +12,475 | $0 | EDGAR |
| 2019-04-23 | Insys Therapeutics, Inc. (INSY) Delisted | Grant (A) | +39,600 | $0 | EDGAR |
| 2019-04-19 | Insys Therapeutics, Inc. (INSY) Delisted | Grant (A) | +39,600 | $0 | EDGAR |
| 2018-08-07 | Insys Therapeutics, Inc. (INSY) Delisted | Mixed | +5,000 | $0 | EDGAR |
| 2017-11-21 | Insys Therapeutics, Inc. (INSY) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.